|
English
|
正體中文
|
简体中文
|
2832153
|
|
???header.visitor??? :
33668162
???header.onlineuser??? :
1215
???header.sponsordeclaration???
|
|
|
|
???tair.name??? >
???browser.page.title.author???
|
"navarro compan v"???jsp.browse.items-by-author.description???
Showing items 1-2 of 2 (1 Page(s) Totally)
1
View [10|25|50] records per page
| 中山醫學大學 |
2021 |
EFFECT OF TOFACITINIB ON PATIENT-REPORTED OUTCOMES IN PATIENTS WITH ACTIVE ANKYLOSING SPONDYLITIS: RESULTS FROM A PHASE 3 TRIAL
|
Navarro-Compan, V; Wei, JCC; Van den Bosch, F; Magrey, M; Wang, L; Fleishaker, D; Cappelleri, JC; Wang, C; Wu, J; Dina, O; Fallon, L; Strand, V |
| 中山醫學大學 |
2020 |
Impact of Ixekizumab on Work Productivity in Patients with Ankylosing Spondylitis: Results from the COAST-V and COAST-W Trials at 52 Weeks
|
Marzo-Ortega, H; Mease, PJ; Rahman, P; Navarro-Compan, V; Strand, V; Dougados, M; Combe, B; Wei, JCC; Baraliakos, X; Hunter, T; Sandoval, D; Li, XQ; Zhu, BJ; Bessette, L; Deodhar, A |
Showing items 1-2 of 2 (1 Page(s) Totally)
1
View [10|25|50] records per page
|
